Product information and disease descriptionProduct descriptionProduct informationPharmacology
Pharmacokinetics
5 evidence topics · 5 sources
Absorption and conversion to the N-glucuronide metabolite: first-in-human single ascending dose study
“A single oral dose of ABX464 (50, 100, 150 or 200 mg) was administered on the morning of day 0 after overnight fasting, with follow-up for 45 days.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“ABX464's C max was observed approximately 2 h after administration in all groups.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“ABX464 was rapidly and substantially metabolized into ABX464-NGlc.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The C max of ABX464-NGlc was observed approximately 4 h post-dose and was about 160-fold higher than that of the parent with a much longer t 1/2 (90-110 h).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The ratio of metabolite to parent drug was consistent across the complete dose range.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Half-lives of the parent compound and the metabolite after repeated doses
Metabolism by glucuronidation and time to steady state
Effect of food on exposure
“The maximum concentration (Cmax) and the area under the concentration-time curve from time zero to infinity (AUC0–∞) of ABX464 were demonstrated to increase with food after a single dose of ABX464 (219% and 188%, respectively).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The apparent terminal elimination half-lives (t1/2s) under fed and fasted conditions were comparable, at about 0.80 h.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The median time to maximum concentration (Tmax) was delayed from 1.5 to 2.8 h, and the ratio of the AUC0–∞ obtained under fed conditions to the AUC0–∞ obtained under fasted conditions (Frel) was 2.69.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The increases in Cmax and AUC0–∞ of the metabolite ABX464–N-glucuronide (ABX464-NGlc) were, however, much more limited when ABX464 was given with food.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The t1/2s were also comparable under the two conditions (around 100 h).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Interindividual variability under fed and fasted conditions
“Interindividual variability tended to decrease when ABX464 was given with food, since the CVs of AUC0–t and AUC0–∞ under fasted conditions were 67% and 57% compared to 42% and 37%, respectively, under fed conditions.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote